BioPATH: A Biomarker Study in Asian Patients With HER2+ Advanced Breast Cancer Treated With Lapatinib and Other Anti-Her2 Therapy

Cancer Research and Treatment - South Korea
doi 10.4143/crt.2018.598

Related search